r.iyer
Submits third-party assay reports on material purchased directly. Based in Accra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.75%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041336 | Semaglutide | WWB | WWB-2606-N3192 | Kestrel | 2026-Q3 | 98.56 | 4.15 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043354 | Leuprolide | WXT | WXT-2604-K2596 | Janoshik | 2026-Q3 | 99.41 | 5.44 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042522 | Semax | Homopeptide | HOMO-2605-S5227 | Nordanalyt | 2026-Q3 | 99.93 | 5.49 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043043 | 5-Amino-1MQ | KP | KP-2511-W5347 | Janoshik | 2026-Q2 | 99.58 | 4.16 | 101.1 | Buyer-sourced | 0 | FAIL |
| AX-2026-042929 | Mazdutide | MKM | MKM-2511-N3837 | Janoshik | 2026-Q2 | 98.75 | 6.73 | 103.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020214 | Semaglutide | GGPeps | GGPE-2501-W1875 | Janoshik | 2025-Q1 | 98.67 | 5.59 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005324 | Tirzepatide | QST | QST-2409-K5786 | Janoshik | 2024-Q4 | 98.03 | 6.36 | 89.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005345 | Tirzepatide | SIG | SIG-2404-6658 | PeptideMeter | 2024-Q3 | 97.49 | 7.59 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004679 | Semaglutide | Homopeptide | HOMO-2401-R3356 | VendorInvestigate | 2024-Q2 | 98.79 | 2.13 | — | Buyer-sourced | 0 | PASS |